Fundraising Fox
🦊/People
Sign in

Albert Cha

Investor

Managing Partner at Frazier Life Sciences · Managing Partner at Vivo Capital · Chairman at Ascendis Pharma A/S · Board director at Aclaris Therapeutics

Palo Alto

Find your path to Albert

177 people in our graph share verified history with Albert — schools, employers, funds. One of them is your warm intro.

Mark SiegelunlockedAlbert: together at Oracle (1992–1993)
×9Albert: together at Oracle
Albert: together at Ascendis Pharma A/S
Albert: together at Aclaris Therapeutics

About

Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.

Contact· published on Albert's own website

Invests in

BiotechMedical Devices

Board director at Aclaris Therapeutics

Intro paths

→

In turn, Albert can intro founders to Aclaris Therapeutics's investors below.

Aclaris Therapeutics's investors · 8

Aisling CapitalNew YorkAPERTURE Venture PartnersBoston · $1M – $5M checksF-Prime CapitalCambridge · $3M – $10M checks · since 2012Foresite CapitalWest HollywoodRA CapitalBostonSofinnova Venture PartnersMenlo Park · since 2020Sofinnova VenturesMenlo Park · $100K – $15M checksVivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Aclaris Therapeutics

NW
Neal WalkerExecutive Officer, Director
KA
Kamil Ali-JacksonExecutive Officer
SDStuart D. Shanler
Stuart D. ShanlerExecutive Officer

Experience

  1. Frazier Life SciencesManaging Partnercurrent2021 — present
  2. Ascendis PharmaChairmancurrent2021 — presentCopenhagen, Capital Region, Denmark
  3. KalVista Pharmaceuticals, Inc.Board Member2016 — 2024Cambridge, Massachusetts, United States
  4. Vivo CapitalManaging Partner2000 — 2020
  5. OracleConsultant1992 — 1993

Skills & more

Pharmaceutical Industry17Medical Devices19Clinical Trials6Start-ups16Biopharmaceuticals4Corporate Development5MergersBusiness StrategyPrivate Equity1Due Diligence2Entrepreneurship3Valuation
+8 moreStrategic PlanningCorporate FinanceStrategyFinancial ModelingManagement ConsultingProduct ManagementProduct DevelopmentM&A experience

From Albert's professional profile.

Investments

Board seats

Aclaris TherapeuticsAscendis Pharma A/SBiohaven PharmaceuticalsKalVista Pharmaceuticals

Per the firm's website.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences

Network7

Chen Bian
Associate at Vivo Capital
Daisy Xu
Managing Director at Vivo Capital
Daniel Qin
Associate at Vivo Capital
David Liu
Managing Director at Vivo Capital
Dr Arjun Goyal
Investment committee member at Tin Alley Ventures
Fabianne Nordenson
Principal at Vivo Capital
Gaurav Aggarwal
Managing Director at Vivo Capital

Investors connected to Albert in public investor directories — a warm-intro map.

Frequently asked questions

Who is Albert Cha?
Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.
Where does Albert Cha work?
Albert Cha is Managing Partner at Frazier Life Sciences and Board director at Aclaris Therapeutics.
What does Albert Cha invest in?
Albert Cha invests in Biotech, Medical Devices.
What boards does Albert Cha sit on?
Albert Cha holds tracked board seats at Aclaris Therapeutics, Ascendis Pharma A/S, Biohaven Pharmaceuticals, KalVista Pharmaceuticals.
Where did Albert Cha go to school?
Albert Cha studied at Stanford University (M.S., Electrical Engineering); Stanford University (B.S., Electrical Engineering); UCLA (M.D./Ph.D., Neuroscience).

Same school

Shared employers